Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carmel AS, Shieh A, Bang H, Bockman RS (2012) The 25(OH)D level needed to maintain a favorable bisphosphonate response is >/=33 ng/ml. Osteoporos Int 23:2479–2487

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Peris P, Martinez-Ferrer A, Monegal A, Martinez de Osaba MJ, Muxi A, Guanabens N (2012) 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone 51:54–58

    Article  CAS  PubMed  Google Scholar 

  3. Ishijima M, Sakamoto Y, Yamanaka M et al (2009) Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women. Calcif Tissue Int 85:398–404

    Article  CAS  PubMed  Google Scholar 

  4. Deane A, Constancio L, Fogelman I, Hampson G (2007) The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord 8:3

    Article  PubMed Central  PubMed  Google Scholar 

  5. Stoch SA, Saag KG, Greenwald M et al (2009) Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. J Rheumatol 36:1705–1714

    Article  CAS  PubMed  Google Scholar 

  6. Reid DM, Hughes RA, Laan RF et al (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study J Bone Miner Res 15:1006–1013

    CAS  Google Scholar 

  7. Reid DM, Devogelaer JP, Saag K et al (2009) Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 373:1253–1263

    Article  CAS  PubMed  Google Scholar 

  8. Davidson ZE, Walker KZ, Truby H (2012) Clinical review: Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 97:738–744

    Article  CAS  PubMed  Google Scholar 

  9. Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario San Cecilio, Granada, Spain

    M. Ortego-Jurado, R. Ríos-Fernández, J. L. Callejas-Rubio & N. Ortego-Centeno

  2. Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, Spain

    M. Á. Gonzalez-Gay

Authors
  1. M. Ortego-Jurado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Ríos-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. L. Callejas-Rubio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Á. Gonzalez-Gay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Ortego-Centeno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Ortego-Centeno.

Additional information

A reply to this comment can be found at DOI 10.1007/s00198-014-2711-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortego-Jurado, M., Ríos-Fernández, R., Callejas-Rubio, J.L. et al. Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy. Osteoporos Int 25, 2157–2158 (2014). https://doi.org/10.1007/s00198-014-2713-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-014-2713-6

Keywords

Search

Navigation